Home › Trial NCT03488810
Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
- Trial IDNCT03488810
- StatusWithdrawn
- PhasePhase 3
- Study typeInterventional
- SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
- Enrollment—
- Start date2020-03-10
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.